Science Current Events | Science News | Brightsurf.com
 

Ohio State researchers discover hereditary predisposition of melanoma of the eye

December 16, 2011

COLUMBUS, Ohio - Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and possibly other types of cancer.

The hereditary cancer syndrome is caused by an inherited mutation in a gene called BAP1, researchers say.

The findings suggest that BAP1 mutations cause the disease in a small subset of patients with hereditary uveal melanoma and other cancers.

Uveal melanoma is a cancer of the eye involving the iris, ciliary body, or choroid, which are collectively known as the uvea. These tumors arise from the pigment cells, also known as melanocytes that reside within the uvea giving color to the eye. This is the most common type of eye tumor in adults.

The findings are reported in the Journal of Medical Genetics.

"We are describing a new cancer genetic syndrome that could affect how patients are treated," said first author Dr. Mohamed H. Abdel-Rahman, researcher at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. "If we know that a patient has this particular gene mutation, we can be more proactive with increased cancer screenings to try to detect these other potential cancers when they are beginning to grow."

Study leader Dr. Frederick H. Davidorf, professor emeritus of ophthalmology at Ohio State University, explained that BAP1 seems to play an important role in regulating cell growth and proliferation, and that loss of the gene helps lead to cancer.

"If our results are verified, it would be good to monitor these patients to detect these cancers early when they are most treatable," said Davidorf, who treats ocular oncology patients at Ohio State along with researcher and physician Dr. Colleen Cebulla.

The study involved 53 unrelated uveal melanoma patients with high risk for hereditary cancer, along with additional family members of one of the study participants. Of the 53 patients in the study, researchers identified germline variants in BAP1 in three patients.

"We still don't know exactly the full pattern of cancers these patients are predisposed to, and more studies are needed," said Abdel-Rahman, also an assistant professor of ophthalmology and division of human genetics at Ohio State University College of Medicine.

"So far, we've identified about six families with this hereditary cancer syndrome. We are working with researchers at Nationwide Children's Hospital to develop a clinical test to screen for the BAP1 gene mutation," he said. "Families with this cancer syndrome should be screened for inherited mutations that increase their risk for developing several other cancers."

Ohio State University Medical Center


Related Melanoma Current Events and Melanoma News Articles


Dogs accelerate the advance of new cancer treatments for both pets and people
A Science Translational Medicine review suggests integrating dogs with naturally occurring cancers into studies of new drug therapeutics could result in better treatments for our four-legged friends while helping inform therapeutic development for human cancers.

Breakthrough in generating embryonic cells that are critical for human health
Neural crest cells arise early in the development of vertebrates, migrate extensively through the embryo, and differentiate to give rise to a wide array of diverse derivatives.

Height influences risk of cardiovascular disease, diabetes, and cancer
Height is largely genetically determined, but in recent decades the height of children and adults has steadily increased throughout the world: In adulthood the children are almost always significantly taller than their parents.

Researchers identify potential targeted therapy for lung cancer using fly model
A drug approved by the Food and Drug Administration (FDA) for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research from the Icahn School of Medicine at Mount Sinai.

New mouse-human modeling system enables study of disease development in vivo
Whitehead Institute researchers have created a new mouse-human modeling platform that could be used to study neural crest development as well as the modeling of a variety of diseases, including such cancers as melanoma and neurofibromatosis.

Optogenetic technology developed at UMMS uses light to trigger immunotherapy
A new optogenetic technology developed by scientists at the University of Massachusetts Medical School and Texas A&M Health Science Center Institute of Biosciences & Technology, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice.

Inherited genetic markers may predict melanoma survival -- and help plot course of disease
Melanoma is the most dangerous and lethal form of skin cancer. But just how long will a patient survive following the removal of a melanoma tumor?

Twin study estimates familial risks of 23 different cancers
A large new study of twins has found that having a twin sibling diagnosed with cancer poses an excess risk for the other twin to develop any form of cancer.

Three hits to fight lung cancer
Although the most common type of lung cancer - non-small cell lung cancer (NSCLC) - has recently seen major treatment advances in some genetic subtypes, other subtypes continue to evade effective treatment.

No significant differences in recurrence rates among women with DCIS taking anastrozole or tamoxifen
Postmenopausal women with ductal carcinoma in situ (DCIS) had similar outcomes with disease recurrence whether they took tamoxifen or the aromatase inhibitor anastrozole for five years after surgery, but women in the two groups had different side effects.
More Melanoma Current Events and Melanoma News Articles

Beating Melanoma: A Five-Step Survival Guide (A Johns Hopkins Press Health Book)

Beating Melanoma: A Five-Step Survival Guide (A Johns Hopkins Press Health Book)
by Steven Q. Wang (Author)


Dr. Steven Q. Wang, a world-renowned skin cancer expert, provides an essential guide for people with melanoma and their families. The book’s unique, practical format approaches the disease in two phases, just as people with melanoma need to do. First comes a step-by-step guide for what Dr. Wang calls the "mad rush" phase―an intense and stressful period from diagnosis to completing initial treatment. Dr. Wang's calm guidance helps readers through this critical time, using an easy to understand plan for ensuring optimal treatment and survival outcomes. Once the mad rush phase is over, the "marathon phase" begins―life resumes its normal shape but with lingering concerns about new melanoma and metastases. Here Dr. Wang addresses common questions about prevention and prognosis. Beating...

A Melanoma Patient's Survival Guide: Lemons Really Do Make Lemonade: You Just Have to Add a Little Sugar

A Melanoma Patient's Survival Guide: Lemons Really Do Make Lemonade: You Just Have to Add a Little Sugar
by Sally Welsh (Author)


A Melanoma Patient’s Survival guide: Lemons Really Do Make Lemonade is an effort to bring awareness to the subject of melanoma. This insidious disease is being diagnosed in over 50,000 people a year in the United States alone. Melanoma will affect one in seventy-five people in California. That rate goes up each year. Melanoma can be a silent killer. This heart-warming book was written by a survivor of serious melanoma, Sally Welsh. Sally has shared her experience with thousands of people, and has prepared this book with the hope of making your journey a little easier. Her suggestions deal first of all with the questions you need to ask your doctor, before he cuts into you. You need to know about his initial scanning of you, whether he plans to use a “punch” biopsy or a “scrape”...

Melanoma

Melanoma
by Jonathan S. Zager (Editor), Vernon K. Sondak (Editor), Ragini Kudchadkar (Editor)


Melanoma is a concise handbook that identifies best-practice guidelines and presents the most current procedures for the diagnosis and management of melanoma in a succinct and easy-to-read manner. Chapters cover melanoma pathology, biopsy techniques, staging and risk stratification, surgical treatment of localized melanoma, immunotherapy, radiation therapy, and guidelines for resected melanoma, targeted therapy, cytotoxic chemotherapy, and management of brain metastases, mucosal and ocular melanoma, and pediatric melanoma patients. This handbook is a must-have tool for clinicians directly involved in the care of patients with melanoma, including surgical oncologists, medical oncologists, and radiation oncologists.

Melanoma- Not Just Skin Cancer

Melanoma- Not Just Skin Cancer
by Catherine M. Poole (Author)


All cancer diagnoses are terrifying, but a melanoma diagnosis is both frightening and confusing. When Catherine M. Poole learned she had melanoma twenty-five years ago, she found that most of the literature on melanoma focused on prevention. To add to her understandable alarm, she couldn’t find clear, concise information on treatment options. Poole wanted to be an informed patient, but she had no resources. She survived melanoma and has become a dedicated activist for melanoma research and a staunch patient advocate. Her new book, Melanoma: Not Just Skin Cancer, is a comprehensive guide to melanoma treatments. She tells her own survival story, as well as the stories of others. Since 2012, scientific advances have allowed even those with stage IV melanoma to survive and thrive. Poole...

Melanoma (Cancer Treatment and Research)

Melanoma (Cancer Treatment and Research)
by Howard L. Kaufman (Editor), Janice M. Mehnert (Editor)


Melanoma is one of the most types of cancer. When melanoma is detected at an early stage, treatment is highly successful, but outcomes can be poor when the disease is advanced. There has been significant progress in our understanding of the molecular biology, genetics, and immunology of melanoma over the past decade. This has been accompanied by rapid advances in therapeutic strategies for patients with melanoma. This book provides the clinician and the researcher with a broad understanding of the molecular and cellular pathogenesis of melanoma, explores the clinical characteristics and criteria for clinical and pathological staging of the disease, and provides an overview of current and evolving treatment strategies in the adjuvant, metastatic, and preventive settings. The treatment of...

Histological Diagnosis of Nevi and Melanoma

Histological Diagnosis of Nevi and Melanoma
by Guido Massi (Author), Philip E. LeBoit (Author)


The interpretation of melanocytic tumors represents probably the most difficult task in the field of dermatopathology. The second edition of this text and atlas depicts a broad range of the most important and most challenging melanocytic lesions. Each individual case is illustrated with at least three high-quality color photographs and is commented on at length, highlighting the diagnostic clues. The goal of the authors is to assist the ordinary pathologist in making a precise workable diagnosis in their daily practice. They achieve this by providing simple criteria that will serve as a sound basis for an unequivocal diagnosis of either a benign or a malignant melanocytic neoplasm. The reader will find Histological Diagnosis of Nevi and Melanoma to be an invaluable guide to correct...

Yes, YOU can survive Melanoma Skin Cancer: The Secrets of how I defied all odds and left the Medical Establishment stunned !

Yes, YOU can survive Melanoma Skin Cancer: The Secrets of how I defied all odds and left the Medical Establishment stunned !
by Who Publishing Company


This book is about why having stage 4 (Terminal) Melanoma Skin Cancer can be the best thing that EVER happened to your life.
In fact, my recovery was so miraculous, it changed my Doctor's life too. I went from terminal cancer with less than two months to live to being completely cancer free with three months ! I want you to learn the stunning secrets behind this extraordinary story of how an ordinary man defied ALL odds and left the medical establishment stunned.
This book is a MUST for anyone with Cancer.
I am so convinced this book will change your life forever, I offer an unconditional money back guarantee

I Survived Metastacised Melanoma Cancer!: Hope For Melanoma Sufferers

I Survived Metastacised Melanoma Cancer!: Hope For Melanoma Sufferers
by Frank E. Burdett (Author)


I know the importance of the individual experience of metastacised melanoma cancer, because it is a very special journey. People are prone to forget, such as when one forgets they have a finger, until they hit it; people also forget they have a life until it is very seriously threatened. The worst sentence in this world that a doctor can pronounce is, "I am sorry, but the medical profession can do nothing further for you" This work explores how my wife, Jeannie, who was my home caregiver, and I travelled the cancer journey together. The journey was not the same for Jeannie as it was for me-it was my melanoma cancer, but I was Jeannie's husband, and therefore the stress was that much more for her, as she never knew what further stresses she had to face. This book examines the strengths of...

Understanding Melanoma

Understanding Melanoma
by Md, Perry Robins (Author), Md, Maritza Perez (Contributor)


This valuable handbook, written by two renowned dermatologists, is for melanoma patients, their families, friends, health professionals, and every person interested in staying healthy. Complete with fullcolor photographs, a specially compiled list of support groups and services, and a glossary.

NCCN Guidelines for Patients®: Melanoma

NCCN Guidelines for Patients®: Melanoma
by National Comprehensive Cancer Network® (NCCN®) (Author)


From the medical leaders of 25 of the world’s most renowned cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to melanoma. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of melanoma. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide! Part 1 – Explains the growth and spread of melanoma skin cancer Part 2 – Describes suggested tests used to confirm melanoma and plan treatment Part 3 – Explains how doctors...

© 2016 BrightSurf.com